Stock 4132 GOLDEN BIOTECHNOLOGY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Company Golden Biotechnology Corporation

Equities

4132

TW0004132006

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
28.9 TWD -0.52% Intraday chart for Golden Biotechnology Corporation +2.30% -26.37%
Jan. 18 Golden Biotechnology Corp. Unveils the Findings of Its Phase II Clinical Trial Investigating Antroquinonol CI
2023 Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Golden Biotechnology Corp is a Taiwan-based company mainly engaged in the development of new anti-cancer drugs. The Company's main development projects are novel compounds of Antroquinonol for the treatment of non-small cell lung cancer, acute myeloid leukemia, pancreatic cancer, hyperlipidemia, hepatitis B, and Corona Virus Disease 2019 (Covid-19), which are broadly effective small molecule drugs with no systemic toxicity. The Company is also engaged in the manufacture and sales of health foods and dietary supplements. The main products include antrodia camphorata mycelium capsules and others. The Company sells products in the Taiwan market as well as in other areas of Asia.

Number of employees: 122

Sales per Business

TWD in Million2021Weight2022Weight Delta
Rights Authorization
51.6 %
- - 112 51.6 % -
Healthy Food
48.4 %
82 100.0 % 105 48.4 % +28.91%

Sales per region

TWD in Million2021Weight2022Weight Delta
South Korea
51.6 %
-- 112 51.6 % -
Taiwan
29.0 %
33 40.7 % 63 29.0 % +89.63%
Japan
15.5 %
38 46.9 % 34 15.5 % -12.16%
China
3.5 %
4 4.7 % 8 3.5 % +98.66%
Malaysia
0.5 %
6 7.3 % 1 0.5 % -83.30%
Others
0.0 %
0 0.5 % 0 0.0 % -88.11%

Managers

Managers TitleAgeSince
Ching Tien Su CEO
 Chief Executive Officer - 19-03-03
Li Yue Wu FOU
 Founder - 02-09-26
Mu Tseng Tseng DFI
 Director of Finance/CFO - -
Yue Chun Chen BRD
 Director/Board Member - 09-06-25
Chih Yuan Chen PRN
 Corporate Officer/Principal - 14-01-12

Members of the board

Members of the board TitleAgeSince
Sheng Yung Liu FOU
 Founder - 02-09-26
Li Yue Wu FOU
 Founder - 02-09-26
Yue Chun Chen BRD
 Director/Board Member - 09-06-25
Chi Tsun Li BRD
 Director/Board Member - 07-06-24
Kuo Lun Huang BRD
 Director/Board Member - 21-04-27
Yu Hui Liao BRD
 Director/Board Member - 17-06-07
Jui Chang Huang BRD
 Director/Board Member - 14-05-29
Jin Hu Wu BRD
 Director/Board Member - 17-06-07
Hsing Hao Hsu BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 142,227,000 142,227,000 ( 100.00 %) 0 100.00 %

Company contact information

Golden Biotechnology Corp.

15/F, Unit 6 27 Chung Cheng East Road Section 2

251 70, New Taipei

+

http://www.goldenbiotech.com.tw
address Golden Biotechnology Corporation(4132)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sales per region

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GOLDEN BIOTECHNOLOGY CORPORATION Stock Golden Biotechnology Corporation
-26.37% 126M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.73B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 4132 Stock
  4. Company Golden Biotechnology Corporation